Senate Memorial 12 is a request for the New Mexico Department of Health and University of New Mexico to study psilocybin and research regulatory requirements for a therapeutic program.
February 28, 2024
The findings of a new study suggest that the natural psychedelic DMT may have potential as a treatment for depression.
February 21, 2024
As Arizona lawmakers fight to extend psilocybin research deadlines, bipartisan leaders have introduced new legislation that would legalize psilocybin service centers in the state.
February 2, 2024
The VA will fund research into the potential of MDMA and psilocybin for mental disorders including PTSD and depression.
January 10, 2024
The American Medical Association codes aim to standardize psychedelic treatments and provide coverage and reimbursement.
January 4, 2024
Oregon has made headlines the last few years for its psilocybin treatment centers, which as of the latest available numbers, have administered psilocybin mushrooms to several hundred patients in the program’s launch year.
December 28, 2023
Subjects rated their feelings of connectedness during conversations with a partner.
December 11, 2023
A bipartisan bill in Wisconsin would help military veterans in the state with post-traumatic stress disorder get easier access to hallucinogenic mushrooms.
November 28, 2023